Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00428207 · ClinicalTrials.gov registry record · NA
Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy
A NA study, sponsored by Joslin Diabetes Center.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT00428207 is a NA study that was terminated before completion, run by Joslin Diabetes Center. The registered enrollment target is 4 participants.
The verdict
NCT00428207, a NA study, was terminated before completion, sponsored by Joslin Diabetes Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to determine: 1. whether there is a difference between insulin aspart and insulin lispro in continuous insulin pump therapy 2. whether duration of the insulin infusion set placement effect blood sugar control if the infusion set is in place for longer then 72-96 hours
Interventions
- DRUG Insulin Aspart versus Insulin Lispro
- DRUG Insulin Lispro versus Insulin Aspart
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2007-02 |
| Est. Completion | 2008-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00428207
The ClinicalTrials.gov registry entry for NCT00428207 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Insulin Aspart versus Insulin Lispro is the first listed.
NCT00428207 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00428207 about?
NCT00428207 is a clinical study titled "Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy". The purpose of this study is to determine: 1. whether there is a difference between insulin aspart and insulin lispro in continuous insulin pump therapy 2. whether duration of the insulin infusion set placement effect blood sugar control if the infusion set is in place for longer then 72-96 hours
What is the current status of trial NCT00428207?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2007-02. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00428207?
The interventions under investigation include: Insulin Aspart versus Insulin Lispro (DRUG), Insulin Lispro versus Insulin Aspart (DRUG).
Who is sponsoring clinical trial NCT00428207?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.